Dr. Lora Rabin Dagi Glass, MD

Dr. Dagi Glass practices at Trustees of Columbia University in the City of New York in Fort Lee, New Jersey.

Dr. Dagi Glass' NPI, 1083922686, was assigned on September 16, 2010. Dr. Dagi Glass graduated from Icahn School Of Medicine At Mount Sinai in 2010. Dr. Dagi Glass holds New York license 282695.

Dr. Dagi Glass' primary practice is Trustees of Columbia University in the City of New York, at 400 Kelby St, Fort Lee, NJ 07024 in Bergen County. The practice phone is (646) 317-7111.

Dr. Dagi Glass' primary practice is Trustees of Columbia University in the City of New York in Fort Lee, New Jersey. Dr. Dagi Glass is also affiliated with NewYork-Presbyterian/Weill Cornell Medical Center. The medical group on file is ColumbiaDoctors. Dmand AI also links Dr. Dagi Glass to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Dagi Glass practices, 2 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Dagi Glass' primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Dagi Glass is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Dagi Glass' licenses on file in 3 states: New York, Rhode Island and Massachusetts.

Dmand AI lists conjunctivitis, dry eye, eye infection or inflammation, eyelid inflammation and vision problems among the conditions Dr. Dagi Glass treats.

CMS data shows 1,268 Medicare services from Dr. Dagi Glass across 10 procedure codes in 2024, for 429 Medicare patients. Medicare paid $97,880 for them. Every service was in an office.

CMS counts 429 Medicare patients who saw Dr. Dagi Glass in 2024. The largest group is 75 to 84, with 205 patients. 75% of them have high cholesterol, and 62% have high blood pressure. 10% are also on Medicaid. Their average risk score is 1.01, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Dagi Glass' median patient age at 61, with 61% women.

In 2024, Dr. Dagi Glass wrote 258 Medicare Part D claims for 137 patients. 80% of them were for generic drugs. CMS names the drug for 202 of them, across 5 drugs with 11 or more claims each, at $14,599 in total drug cost. In 2023, CMS named 135 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Dagi Glass for performance year 2024, reported through an alternative payment model (APM). Dr. Dagi Glass accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 48 papers to Dr. Dagi Glass, published from 2014 to 2025. 2022 was the busiest year, with 6. The most frequent topics are Ophthalmology, Internship and Residency and Antibodies, Monoclonal, Humanized. Dr. Dagi Glass has published most often in Ophthalmic Plast Reconstr Surg. Dr. Dagi Glass' most frequent co-authors are Bryan J. Winn, MD, Royce Welford Shen Chen, MD and Suzanne K. Freitag, MD.

CMS Open Payments shows 4 general payments to Dr. Dagi Glass from 3 drug and device companies from 2018 to 2024. Food and beverage make up the largest share, 100% of the total. Amgen Inc. paid the most, $45.

Dr. Dagi Glass graduated from Icahn School Of Medicine At Mount Sinai in 2010.

Dr. Dagi Glass is in network with 13 carriers, including Elevance, Aetna and United Healthcare. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.